Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases · 2000
[Investigation of anti-Toxoplasma gondii antibodies in immunodeficient patients].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang B L, Pan X Z, Yin Y K, Weng X H
Аннотация
OBJECTIVE: To investigate the presence of anti-Taxoplasma gondii antibodies in immunodeficient patients.
METHODS: T. gondii-specific immunoglobulin G (IgG) antibodies in serum samples from 371 immunodeficient patients were detected by enzyme-linked immunosorbent assay (ELISA). The patients were with solid malignancies (including untreated digestive system malignancies and solid malignancies received chemotherapy), chronic liver diseases, patients received immunosuppressant therapy (dermatomyositis, psoriasis, pemphigus, post-renal transplantation, systemic lupus erythematosus and other miscellanies), lymphoma, leukemia and diabetes. 100 normal serum samples served as controls.
RESULTS: The positive rate of patients with solid malignancies received chemotherapy, solid malignancies received chemotherapy, chronic liver diseases, systemic lupus erythematosus and leukemia was 19.0%, 33.3%, 16.5%, 45.4% and 20.0%, respectively, being significantly higher than that of the control group(P < 0.05).
CONCLUSION: The immunosuppressed patients are highly predisposing to secondary T. gondii infection.
METHODS: T. gondii-specific immunoglobulin G (IgG) antibodies in serum samples from 371 immunodeficient patients were detected by enzyme-linked immunosorbent assay (ELISA). The patients were with solid malignancies (including untreated digestive system malignancies and solid malignancies received chemotherapy), chronic liver diseases, patients received immunosuppressant therapy (dermatomyositis, psoriasis, pemphigus, post-renal transplantation, systemic lupus erythematosus and other miscellanies), lymphoma, leukemia and diabetes. 100 normal serum samples served as controls.
RESULTS: The positive rate of patients with solid malignancies received chemotherapy, solid malignancies received chemotherapy, chronic liver diseases, systemic lupus erythematosus and leukemia was 19.0%, 33.3%, 16.5%, 45.4% and 20.0%, respectively, being significantly higher than that of the control group(P < 0.05).
CONCLUSION: The immunosuppressed patients are highly predisposing to secondary T. gondii infection.